Literature DB >> 33852026

Magnetic resonance imaging of pediatric liver tumors.

Anil K Vasireddi1, Madeline E Leo1, Judy H Squires2,3.   

Abstract

Liver tumors in children can be benign or malignant. Although several clinical factors are important in the evaluation of these lesions, MRI is particularly important for lesion characterization and tumor staging. In children, use of a hepatobiliary contrast agent is recommended to evaluate a known or suspected liver lesion. In this review, we discuss the most common benign and malignant pediatric liver tumors, including vascular tumors, mesenchymal hamartoma, focal nodular hyperplasia, hepatocellular adenoma, hepatoblastoma, hepatocellular carcinoma, fibrolamellar hepatocellular carcinoma, undifferentiated embryonal sarcoma and metastases, with emphasis on relevant clinical information and imaging appearance at MRI using hepatobiliary agents.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Children; Gadoxetate disodium; Hepatobiliary contrast agent; Liver; Magnetic resonance imaging; Tumor

Mesh:

Substances:

Year:  2021        PMID: 33852026     DOI: 10.1007/s00247-021-05058-z

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  3 in total

1.  18F-FDG PET/CT findings of mesenchymal hamartoma of the liver in an adolescent.

Authors:  Congcong Yu; Shuang Wu; Xiaofeng Dou; Shuilin Zhao; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-25       Impact factor: 9.236

2.  Advances in the treatment of pediatric solid tumors: A 50-year perspective.

Authors:  Michael P LaQuaglia; Justin T Gerstle
Journal:  J Surg Oncol       Date:  2022-10       Impact factor: 2.885

Review 3.  Advanced Magnetic Resonance Imaging (MRI) Techniques: Technical Principles and Applications in Nanomedicine.

Authors:  Federico Bruno; Vincenza Granata; Flavia Cobianchi Bellisari; Ferruccio Sgalambro; Emanuele Tommasino; Pierpaolo Palumbo; Francesco Arrigoni; Diletta Cozzi; Francesca Grassi; Maria Chiara Brunese; Silvia Pradella; Maria Luisa Mangoni di S Stefano; Carmen Cutolo; Ernesto Di Cesare; Alessandra Splendiani; Andrea Giovagnoni; Vittorio Miele; Roberto Grassi; Carlo Masciocchi; Antonio Barile
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.